Elsevier

The Annals of Thoracic Surgery

Volume 52, Issue 5, November 1991, Pages 1108-1112
The Annals of Thoracic Surgery

Original article
Surgical management of resistant Mycobacterial tuberculosis and other mycobacterial pulmonary infections

https://doi.org/10.1016/0003-4975(91)91289-8Get rights and content

Abstract

Between August 1983 and October 1990, 42 patients with resistant Mycobacterium tuberculosis underwent 44 pulmonary resections. During the same time, 38 patients with mycobacterial infections other than tuberculosis had 41 pulmonary resections. All patients either were poor candidates for medical therapy alone or had existing complications requiring surgical intervention. There was one operative death in each group, both from adult respiratory distress syndrome (postpneumonectomy pulmonary edema). Complications were high, with bronchopleural fistula most commonly occurring after right pneumonectomy in patients infected with Mycobacterium avium with superimposed infection with nonmycobacterial pathogens. In patients undergoing pneumonectomy for resistant Mycobacterium tuberculosis, the left lung was most often resected. It is recommended that if localized disease is present and medical treatment is likely to fail, pulmonary resection should be performed for resistant Mycobacterium tuberculosis infection after 3 months of drug-specific therapy. Muscle flaps were used frequently to avoid residual space and bronchial stump problems. Earlier resection in patients with indolent nontuberculous mycobacterial pulmonary infections is advocated before extensive polymicrobial contamination and right lung destruction.

References (7)

There are more references available in the full text version of this article.

Cited by (170)

  • Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure

    2023, eClinicalMedicine
    Citation Excerpt :

    This finding suggests that factors other than the burden of FDG-avid disease in the non-resected lung are associated with treatment outcome. The post-surgical outcomes reported in this study are considerably worse than in previous reports for DR-TB from other settings and eras.14,25–30 However, bedaquiline and linezolid were not widely available at the time, and the degree of drug resistance, prevalence of pre-operative culture positivity, and degree of HIV positivity at the time of surgery were much higher in our study.

  • Bronchopleural Fistula Following Anatomical Lung Resection

    2021, Encyclopedia of Respiratory Medicine, Second Edition
View all citing articles on Scopus

Presented at the Twenty-seventh Annual Meeting of The Society of Thoracic Surgeons, San Francisco, CA, Feb 18–20, 1991.

View full text